Wason

Response adaptive intervention allocation in stepped-wedge cluster randomized trials

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials

The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol

Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project

Prediction of dementia using diffusion tensor MRI measures: the OPTIMAL collaboration

Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?

**Rheumatology* 2021; DOI:10.1093/rheumatology/keab598

Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential

*BMC Rheumatology* 2021; 5:21

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method

*Biostatistics* 2021; DOI: 10.1093/biostatistics/kxaa055

Revisiting the JOQUER trial: Stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine

*Rheumatology International* 2021; 41(9):1593-1600

A review of Bayesian perspectives on sample size derivation for confirmatory trials

*The American Statistician* 2021; DOI:10.1080/00031305.2021.1901782